Gold, L. S.; Weiss, J. S.; Green, L.; Kircik, L.; Miller, L.; Jacobson, A.; Harris, S. Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Baseline Body Surface Area of 6 -12%. J of Skin 2020, 4, s37.